HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taku Nakashima Selected Research

Nicergoline

7/2014A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline.
7/2011Nicergoline improves dysphagia by upregulating substance P in the elderly.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taku Nakashima Research Topics

Disease

18Neoplasms (Cancer)
07/2022 - 07/2015
14Lung Neoplasms (Lung Cancer)
07/2022 - 01/2018
13Interstitial Lung Diseases (Interstitial Lung Disease)
07/2022 - 01/2018
13Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021 - 05/2008
13Fibrosis (Cirrhosis)
01/2021 - 05/2008
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 11/2017
7Adenocarcinoma of Lung
01/2022 - 06/2017
7Idiopathic Pulmonary Fibrosis
01/2021 - 02/2007
6Pneumonia (Pneumonitis)
10/2022 - 05/2008
5Asthma (Bronchial Asthma)
12/2022 - 09/2011
5Lung Injury
12/2021 - 01/2017
4Bronchiectasis
02/2021 - 01/2018
3Disease Progression
07/2022 - 01/2020
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2021 - 10/2017
3Inflammation (Inflammations)
01/2021 - 11/2017
2Respiratory Insufficiency (Respiratory Failure)
02/2022 - 01/2017
2Emphysema
04/2021 - 01/2018
2Disseminated Intravascular Coagulation
02/2021 - 02/2011
2Venous Thromboembolism
02/2021 - 03/2019
2Acute Lung Injury
10/2020 - 01/2020
2Neoplasm Metastasis (Metastasis)
09/2020 - 06/2017
2Intracranial Embolism
01/2020 - 03/2019
2Breast Neoplasms (Breast Cancer)
01/2019 - 01/2009
2Lewis Lung Carcinoma
09/2018 - 12/2015
1Exophthalmos (Proptosis)
12/2022
1Immunoglobulin G4-Related Disease
12/2022
1Rheumatoid Arthritis
10/2022
1Meningoencephalitis
10/2022
1Chickenpox
10/2022
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
04/2022
1Pulmonary Alveolar Proteinosis
02/2022
1Glucose Intolerance
11/2021
1Hyperglycemia
11/2021
1Radiation Pneumonitis
10/2021
1Esophagitis
09/2021
1Pneumococcal Pneumonia
04/2021
1Thrombosis (Thrombus)
02/2021

Drug/Important Bio-Agent (IBA)

12Bleomycin (Blenoxane)FDA LinkGeneric
01/2021 - 05/2008
10LigandsIBA
07/2022 - 02/2011
6Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2011
6CytokinesIBA
01/2021 - 05/2008
4indium-bleomycinIBA
01/2021 - 06/2013
3ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2016
3HMGB1 Protein (HMG1)IBA
12/2021 - 01/2020
3AntigensIBA
04/2021 - 09/2011
3Pharmaceutical PreparationsIBA
02/2021 - 01/2009
3Small Interfering RNA (siRNA)IBA
01/2021 - 12/2015
3Proteins (Proteins, Gene)FDA Link
10/2020 - 12/2015
3pembrolizumabIBA
03/2020 - 03/2019
3AntibodiesIBA
11/2019 - 12/2018
3Plasminogen Activator Inhibitor 1IBA
01/2019 - 01/2016
3Plasminogen Activators (Plasminogen Activator)IBA
01/2019 - 01/2016
2Immunoglobulin G (IgG)IBA
12/2022 - 04/2022
2SteroidsIBA
12/2022 - 01/2018
2Prednisolone (Predate)FDA LinkGeneric
12/2022 - 01/2018
2Cisplatin (Platino)FDA LinkGeneric
02/2021 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2017
2Messenger RNA (mRNA)IBA
01/2021 - 01/2021
2Immune Checkpoint InhibitorsIBA
11/2020 - 09/2019
2suplatast tosilateIBA
01/2019 - 01/2017
2ChemokinesIBA
01/2019 - 01/2017
2Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2019 - 12/2018
2PowdersIBA
09/2018 - 12/2015
2CD13 Antigens (Alanine Aminopeptidase)IBA
01/2018 - 07/2015
2NicergolineIBA
07/2014 - 07/2011
2CollagenIBA
05/2008 - 02/2007
1GlucocorticoidsIBA
12/2022
1dupilumabIBA
12/2022
1InterleukinsIBA
12/2022
1Interleukin-13IBA
12/2022
1Valacyclovir (Valtrex)FDA LinkGeneric
10/2022
1Methotrexate (Mexate)FDA LinkGeneric
10/2022
1iguratimodIBA
10/2022
1tepotinibIBA
06/2022
1capmatinibIBA
06/2022
1ParaffinIBA
04/2022
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
04/2022
1osimertinibIBA
01/2022
1mepolizumabIBA
01/2022
1Advanced Glycation End ProductsIBA
11/2021
1Hemoglobins (Hemoglobin)IBA
11/2021
1Carboplatin (JM8)FDA LinkGeneric
11/2021
1Etoposide (VP 16)FDA LinkGeneric
11/2021
1atezolizumabIBA
11/2021
1MicroRNAs (MicroRNA)IBA
09/2021
1Urea (Carbamide)FDA LinkGeneric
04/2021
1NitrogenIBA
04/2021
1Rheumatoid FactorIBA
03/2021
1AutoantibodiesIBA
03/2021
1Antinuclear AntibodiesIBA
03/2021
1Indicators and Reagents (Reagents)IBA
02/2021

Therapy/Procedure

14Drug Therapy (Chemotherapy)
07/2022 - 06/2017
5Radiotherapy
10/2021 - 06/2017
5Therapeutics
01/2021 - 07/2015
4Traction
02/2021 - 01/2018
3Chemoradiotherapy
09/2021 - 10/2017
2Oral Administration
10/2022 - 06/2017
2Catheters
01/2020 - 01/2018
1Operative Surgical Procedures
07/2022
1General Anesthesia
02/2022